DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Virtual Event

2021 年 03 月 08 日 9:45 上午 - 2021 年 03 月 10 日 5:05 下午

(US Eastern Standard Time)

Horsham, PA 19044

Advertising and Promotion Regulatory Affairs Conference

Session 4: Using Influencers, Endorsers, and Testimonials in Your #Sponsored Campaigns

Session Chair(s)

Joanne  Hawana, JD, MS

Joanne Hawana, JD, MS

Member

Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States

Heather  Banuelos, JD

Heather Banuelos, JD

Counsel

King & Spalding LLP, United States

In today’s world of social media and the rise in influencer marketing throughout all industries, patient and physician endorsements for medical products can lend authenticity and emotional appeal to the biopharma marketing mix. To integrate testimonials, ambassadors, influencers, and spokespersons into their toolbox, marketers must understand the FDA and FTC laws, rules, and regulations applying to endorsements. This session will explore the legal and regulatory compliance issues that arise, as well as ways to safely, ethically, and transparently harness the great potential of patient and provider voices to full effect.

Learning Objective :
  • Describe FTC requirements for public disclosure of material connections between a marketer and an influencer or expert endorser
  • Describe FDA requirements related to the use of testimonials and endorsements,
  • Identify the key risks and mitigation measures including best practices for training and monitoring brand ambassadors and influencers
  • Discuss best practices for safe, ethical, and transparent patient engagement

Speaker(s)

Laura M Sullivan, JD

Speaker

Laura M Sullivan, JD

Federal Trade Commission, United States

Senior Attorney, Division of Advertising Practices

Nicole  Hoadley, MBA

Speaker

Nicole Hoadley, MBA

Snow Companies LLC, United States

Vice President, Client Services

Anna  Williams, MS

Speaker

Anna Williams, MS

Alkermes, United States

Senior Director

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。